For: | Virdis F, Tacci S, Messina F, Varcada M. Hemophagocytic lymphohistiocytosis caused by primary Epstein-Barr virus in patient with Crohn’s disease. World Journal of Gastrointestinal Surgery 2013; 5(11): 306-308 [PMID: 24520429 DOI: 10.4240/wjgs.v5.i11.306] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v5/i11/306.htm |
Number | Citing Articles |
1 |
Hui Zhang, Shuliang Zhao, Zhijun Cao. Impact of Epstein–Barr virus infection in patients with inflammatory bowel disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1001055
|
2 |
Jens Vikse, Daniel Limi Cacic, Arne Carlsen, Trond Johan Cooper, Tore Grimstad. En mann i 30-årene med ulcerøs kolitt og pancytopeni. Tidsskrift for Den norske legeforening 2016; 136(11): 1010 doi: 10.4045/tidsskr.15.0958
|
3 |
Ersilia M. DeFilippis, Robbyn Sockolow, Elaine Barfield. Health Care Maintenance for the Pediatric Patient With Inflammatory Bowel Disease. Pediatrics 2016; 138(3) doi: 10.1542/peds.2015-1971
|
4 |
Saurabh Kapur, Stephen B. Hanauer. The Evolving Role of Thiopurines in Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 2019; 17(3): 420 doi: 10.1007/s11938-019-00244-3
|
5 |
Ruth de Francisco, Andrés Castaño‐García, Susana Martínez‐González, Isabel Pérez‐Martínez, Ana J. González‐Huerta, Lucía R. Morais, María S. Fernández‐García, Santiago Jiménez, Susana Díaz‐Coto, Pablo Flórez‐Díez, Adolfo Suárez, Sabino Riestra. Impact of Epstein‐Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2018; 48(7): 723 doi: 10.1111/apt.14933
|
6 |
Lilia Davenport, Jamie Chin-Hon, Juri Chung, Xian Jie Cindy Chen, Jeffrey Schneider. 6-Mercaptopurine and Macrophage Activation Syndrome Case Report and Review of the Literature. Journal of Pharmacy Practice 2023; 36(4): 1015 doi: 10.1177/08971900221081617
|
7 |
Bárbara Brambilla, Amanda Machado Barbosa, Cassiano da Silva Scholze, Floriano Riva, Lislene Freitas, Raul Angelo Balbinot, Silvana Balbinot, Jonathan Soldera. Hemophagocytic Lymphohistiocytosis and Inflammatory Bowel Disease: Case Report and Systematic Review. Inflammatory Intestinal Diseases 2020; 5(2): 49 doi: 10.1159/000506514
|
8 |
Victoria Grossi, Jeffrey S. Hyams. The safety of treatment options for pediatric Crohn’s disease. Expert Opinion on Drug Safety 2016; 15(10): 1383 doi: 10.1080/14740338.2016.1203418
|
9 |
Grace Thompson, Dominic Pepperell, Ian Lawrence, Benjamin David McGettigan. Crohn's disease complicated by Epstein-Barr virus-driven haemophagocytic lymphohistiocytosis successfully treated with rituximab. BMJ Case Reports 2017; : bcr2016218578 doi: 10.1136/bcr-2016-218578
|
10 |
Jocelyn A Ricard, River Charles, Carolina Gil Tommee, Sophia Yohe, W Robert Bell, Margaret E Flanagan. Epstein Virus Barr-Positive Diffuse Large B-Cell Lymphoma Associated with Hemophagocytic Lymphohistiocytosis. Journal of Neuropathology & Experimental Neurology 2020; 79(8): 915 doi: 10.1093/jnen/nlaa061
|
11 |
T. Kucharzik, A. Dignass, R. Atreya, B. Bokemeyer, P. Esters, K. Herrlinger, K. Kannengiesser, P. Kienle, J. Langhorst, A. Lügering, S. Schreiber, A. Stallmach, J. Stein, A. Sturm, N. Teich, B. Siegmund. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009. Zeitschrift für Gastroenterologie 2023; 61(08): 1046 doi: 10.1055/a-2060-0935
|
12 |
Vincenzo Craviotto, Federica Furfaro, Laura Loy, Alessandra Zilli, Laurent Peyrin-Biroulet, Gionata Fiorino, Silvio Danese, Mariangela Allocca. Viral infections in inflammatory bowel disease: Tips and tricks for correct management. World Journal of Gastroenterology 2021; 27(27): 4276-4297 doi: 10.3748/wjg.v27.i27.4276
|
13 |
T. Kucharzik, A. Dignass, R. Atreya, B. Bokemeyer, P. Esters, K. Herrlinger, K. Kannengiesser, P. Kienle, J. Langhorst, A. Lügering, S. Schreiber, A. Stallmach, J. Stein, A. Sturm, N. Teich, B. Siegmund. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2). Zeitschrift für Gastroenterologie 2024; 62(05): 769 doi: 10.1055/a-2271-0994
|
14 |
V. Mitsialis, Y. Wu, B. Gewurz, R. Bleday, L. A. Doyle, R. W. Winter, M. J. Hamilton. Raising the Barr: An Unexpected Lesion at Ileal–Cecal Resection. Digestive Diseases and Sciences 2019; 64(2): 353 doi: 10.1007/s10620-018-5410-z
|
15 |
Maria Do Céu Espinheira, Isabel Pinto Pais, Ivete Afonso, Jorge Ferreira, Eunice Trindade, Jorge Amil-Dias. Epstein-Barr Virus Infection and Thiopurine Therapy in a Pediatric Population with Inflammatory Bowel Disease. GE - Portuguese Journal of Gastroenterology 2020; 27(5): 318 doi: 10.1159/000507199
|
16 |
Monica I. Ardura, Sima S. Toussi, Jane D. Siegel, Ying Lu, Athos Bousvaros, Wallace Crandall. NASPGHAN Clinical Report. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(1): 130 doi: 10.1097/MPG.0000000000001188
|
17 |
Jeffrey S. Hyams, Marla C. Dubinsky, Robert N. Baldassano, Richard B. Colletti, Salvatore Cucchiara, Johanna Escher, William Faubion, John Fell, Benjamin D. Gold, Anne Griffiths, Sibylle Koletzko, Subra Kugathasan, James Markowitz, Frank M. Ruemmele, Gigi Veereman, Harland Winter, Nicholas Masel, Chu Ri Shin, Kezhen L. Tang, Meena Thayu. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease. Gastroenterology 2017; 152(8): 1901 doi: 10.1053/j.gastro.2017.02.004
|
18 |
Chip Alex Bowman, Garrett Lawlor. Cancer Screening in Inflammatory Bowel Disease. 2019; : 61 doi: 10.1007/978-3-030-15301-4_5
|
19 |
Saurabh Kapur, Stephen B. Hanauer. The Evolving Role of Thiopurines in Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 2019; 17(4): 435 doi: 10.1007/s11938-019-00249-y
|
20 |
Stella Hartono, Michelina Rosa Ippoliti, Maria Mastroianni, Ricardo Torres, Nicholas L. Rider. Gastrointestinal Disorders Associated with Primary Immunodeficiency Diseases. Clinical Reviews in Allergy & Immunology 2019; 57(2): 145 doi: 10.1007/s12016-018-8689-9
|
21 |
T Kucharzik, P Ellul, T Greuter, J F Rahier, B Verstockt, C Abreu, A Albuquerque, M Allocca, M Esteve, F A Farraye, H Gordon, K Karmiris, U Kopylov, J Kirchgesner, E MacMahon, F Magro, C Maaser, L de Ridder, C Taxonera, M Toruner, L Tremblay, M Scharl, N Viget, Y Zabana, S Vavricka. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2021; 15(6): 879 doi: 10.1093/ecco-jcc/jjab052
|
22 |
Torsten Kucharzik, Axel U. Dignass, Raja Atreya, Bernd Bokemeyer, Philip Esters, Klaus Herrlinger, Klaus Kannengießer, Peter Kienle, Jost Langhorst, Andreas Lügering, Stefan Schreiber, Andreas Stallmach, Jürgen Stein, Andreas Sturm, Niels Teich, Britta Siegmund. Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline. Zeitschrift für Gastroenterologie 2020; 58(12): e241 doi: 10.1055/a-1296-3444
|